Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 1998

View Archived Issues

Health Canada gives the go-ahead for clinical testing of TH-9402

Millennium, Wyeth-Ayerst identify another CNS gene target

Fuisz and Novopharm enter agreements for CEFORM CR technology

Cognition-enhancing and antidepressant agent available from BTG

Intercardia signs license to develop drug for IBD

Hybridon and Searle extend and expand antisense research collaboration

Novel gamma-aminobutyric acids related to gabapentin prepared at Warner-Lambert

Advanced Viral Research to initiate clinical trials with Reticulose in Mexico

Dainippon's new agents for urinary incontinence

New heterocyclic compounds inhibit cardiac chymase activity

Antiplatelet agents in the pipeline at Boehringer Ingelheim

Daiichi patents compounds for enhancing bacterial sensitivity to antimicrobial agents

Cypress Bioscience files PMA for Prosorba Column

AIT-082: a new neuroregenerative compound

Effects of RGH-2716 on neurotransmitter release and cerebral energy metabolism

Mechanism of action, anxiolytic and anticonvulsant activity of AWD-131-138

NDA filed for magainin antibiotic for infected diabetic foot ulcers

Biogen: Q2 1998 highlights

Multiyear drug delivery agreement signed by Bioglan and Novo Nordisk

Dura acquires U.S. marketing rights to Myambutol

Cel-Sci, U of Maryland receive state funding for TB test